Harris Brian A, Berger Ann M, Mitchell Sandra A, Steinberg Seth M, Baker Karen L, Handel Daniel L, Bolle Jacques L, Bush Eric G, Avila Daniele, Pavletic Steven Z
Pain and Palliative Care Service, National Institutes of Health Clinical Center, National Cancer Institute, Bethesda, Maryland 20892, USA.
J Support Oncol. 2010 May-Jun;8(3):119-25.
Spiritual well-being (Sp-WB) is a resource that supports adaptation and resilience, strengthening quality of life (QOL) in patients with cancer or other chronic illnesses. However, the relationship between Sp-WB and QOL in patients with chronic graft-versus-host disease (cGVHD) remains unexamined. Fifty-two participants completed the Functional Assessment of Chronic Illness Therapy-Spiritual WellBeing (FACIT-Sp) questionnaire as part of a multidisciplinary study of cGVHD. Sp-WB was generally high. Those with the lowest Sp-WB had a significantly longer time since diagnosis of cGVHD (P = 0.05) than those with higher Sp-WB. There were no associations between Sp-WB and demographics, cGVHD severity, or intensity of immunosuppression. Participants with the lowest Sp-WB reported inferior physical (P = 0.0009), emotional (P = 0.003), social (P = 0.027), and functional well-being (P < 0.0001) as well as lower overall QOL (P < 0.0001) compared with those with higher Sp-WB. They also had inferior QOL relative to population norms. Differences between the group reporting the lowest Sp-WB and those groups who reported the highest Sp-WB scores consistently demonstrated a significant difference for all QOL subscales and for overall QOL. Controlling for physical, emotional, and social well-being, Sp-WB was a significant independent predictor of contentment with QOL. Our results suggest that Sp-WB is an important factor contributing to the QOL of patients with cGVHD. Research is needed to identify factors that diminish Sp-WB and to test interventions designed to strengthen this coping resource in patients experiencing the late effects of treatment.
精神健康(Sp-WB)是一种有助于适应和恢复力的资源,可增强癌症或其他慢性病患者的生活质量(QOL)。然而,慢性移植物抗宿主病(cGVHD)患者的Sp-WB与QOL之间的关系仍未得到研究。作为一项cGVHD多学科研究的一部分,52名参与者完成了慢性病治疗功能评估-精神健康(FACIT-Sp)问卷。Sp-WB总体较高。Sp-WB最低的患者自cGVHD诊断以来的时间显著长于Sp-WB较高的患者(P = 0.05)。Sp-WB与人口统计学、cGVHD严重程度或免疫抑制强度之间无关联。与Sp-WB较高的参与者相比,Sp-WB最低的参与者在身体(P = 0.0009)、情感(P = 0.003)、社交(P = 0.027)和功能健康(P < 0.0001)方面表现较差,总体QOL也较低(P < 0.0001)。他们的QOL相对于人群规范也较差。报告Sp-WB最低的组与报告Sp-WB得分最高的组之间的差异在所有QOL子量表和总体QOL上均持续显示出显著差异。在控制身体、情感和社交健康后,Sp-WB是QOL满意度的重要独立预测因素。我们的结果表明,Sp-WB是影响cGVHD患者QOL的重要因素。需要开展研究以确定降低Sp-WB的因素,并测试旨在增强接受治疗后期影响患者这种应对资源的干预措施。